A study led by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified an
abnormal metabolic pathway that drives cancer -
cell growth in a
particular glioblastoma subtype.